CytRx Corporation (CYTR) financial statements (2022 and earlier)

Company profile

Business Address 11726 SAN VICENTE BOULEVARD
LOS ANGELES, CA 90049
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,77010,00316,13021,37337,64356,95957,297
Cash and cash equivalents6,77010,00316,13021,37337,64356,95922,261
Short-term investments      35,035
Receivables20032581497,5291844,593
Assets held-for-sale, not part of disposal group   81   
Other undisclosed current assets1,3101,0951,0669131,9143,4342,402
Total current assets:8,28011,42317,20522,51647,08760,57764,292
Noncurrent Assets
Operating lease, right-of-use asset397580 
Property, plant and equipment334043441,0431,9601,468
Intangible assets, net (including goodwill)    184184184
Goodwill    184184184
Other noncurrent assets171784134491,081
Other undisclosed noncurrent assets   325   
Total noncurrent assets:447637504101,2612,1922,732
TOTAL ASSETS:8,72712,06017,25522,92648,34862,77067,024
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,6642,5842,0411,6455,4787,32810,627
Accounts payable1,4711,4028881,2354,1226,4068,059
Accrued liabilities9329668853609604352,041
Employee-related liabilities26121526850396487527
Debt    10,6005,482 
Derivative instruments and hedges, liabilities    5273,789693
Disposal group, including discontinued operation   603   
Other undisclosed current liabilities1,070190931613,5982,90811,625
Total current liabilities:3,7342,7742,0502,56430,20219,50822,945
Noncurrent Liabilities
Long-term debt and lease obligation216415   18,485 
Long-term debt, excluding current maturities     18,485 
Operating lease, liability216415 
Other undisclosed noncurrent liabilities(216)(415)     
Total noncurrent liabilities:216415   18,485 
Total liabilities:3,9503,1892,0502,56430,20237,99322,945
Temporary equity, carrying amount4,023      
Stockholders' equity
Stockholders' equity attributable to parent, including:7548,87115,20520,36218,14524,77744,079
Common stock393634342811166
Additional paid in capital484,791479,562479,198477,193468,969437,424409,107
Accumulated deficit(484,076)(470,727)(464,027)(456,864)(450,852)(415,866)(365,095)
Other undisclosed stockholders' equity attributable to parent     3,108 
Total stockholders' equity:7548,87115,20520,36218,14524,77744,079
TOTAL LIABILITIES AND EQUITY:8,72712,06017,25522,92648,34862,77067,024

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues   250100200100
Revenue, net100200100
Gross profit:   250100200100
Operating expenses(12,077)(6,829)(7,861)(8,498)(32,971)(52,458)(63,378)
Operating loss:(12,077)(6,829)(7,861)(8,248)(32,871)(52,258)(63,278)
Nonoperating income (expense)(7)129339358349414254
Investment income, nonoperating 119352356366255234
Foreign currency transaction loss, before tax(22)      
Other nonoperating income (expense) 10(13)3(16)15920
Interest and debt expense   (1,716)(3,831)(2,755) 
Loss from continuing operations before equity method investments, income taxes:(12,084)(6,700)(7,522)(9,606)(36,353)(54,598)(63,024)
Other undisclosed income (loss) from continuing operations before income taxes(1,093)  5271,3683,8284,438
Loss from continuing operations before income taxes:(13,177)(6,700)(7,522)(9,079)(34,986)(50,770)(58,586)
Income tax expense (benefit) (1)1(1)(1)(1)(1)
Net loss:(13,177)(6,701)(7,521)(9,079)(34,986)(50,771)(58,587)
Other undisclosed net income (loss) attributable to parent  359(3,634)   
Net loss attributable to parent:(13,177)(6,701)(7,163)(12,714)(34,986)(50,771)(58,587)
Preferred stock dividends and other adjustments(172)    (314) 
Net loss available to common stockholders, diluted:(13,348)(6,701)(7,163)(12,714)(34,986)(51,085)(58,587)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(13,177)(6,701)(7,521)(9,079)(34,986)(50,771)(58,587)
Other comprehensive income (loss)   3(23)(18)(6)
Comprehensive loss, net of tax, attributable to parent:(13,177)(6,701)(7,521)(9,077)(35,009)(50,789)(58,593)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: